– In the largest long-term hypertension trial of an aldosterone synthase inhibitor to date, lorundrostat demonstrated sustained reduction in automated office systolic blood pressure (AOSBP) of 17.8 ...

The webinar presentation will cover financial and business results from AVITA Medical’s recent third-quarter 2026 earnings webcast and will conclude with a Q&A session. Participants are invited to ...

Systemic sclerosis (SSc) data presented at ACR Convergence 2026 showed 83% (5/6) of patients receiving standard lymphodepletion achieved a clinical response (rCRISS-25) at Month 3, with all responders ...

About Autoimmune Myositis Autoimmune myositis is a heterogenous disease spectrum with autoimmune-mediated pathophysiology, characterized by chronic inflammation and progressive muscle weakness, and in ...

MediPharm Labs executive management team will also host a conference call and webcast on November 12 th, 2026, at 10:00 a.m. (Eastern time) to discuss the Company’s financial results.

LifeMD expects to issue its third quarter 2026 earnings press release on or around 4:05 p.m. Eastern time on Thursday, November 12, 2026 followed by the conference call at 4:30 p.m. Eastern time.

Management will host a conference call and webcast the same day at 10:00 a.m. Eastern Time to discuss the results and provide a business update. Participants dialing in by telephone should ask to be ...

Live Webcast To access the webcast, please register through this link: A replay will be archived on the Investors section of Nkarta’s website, About the Ntrust℠ Clinical Trials in Autoimmune Disease ...

EDEN PRAIRIE, Minn., Nov. 06, 2026 (GLOBE NEWSWIRE) -- Sanuwave Health, Inc. (the "Company" or "Sanuwave”) (NASDAQ: SNWV), a leading provider of next-generation FDA-approved wound care products, will ...

Spectral today issued $6.3 million aggregate principal amount of 2026 Notes in the second tranche of the Offering. Together with the $7.7 million aggregate principal amount of 2026 Notes issued in the ...

The Company is planning to host a conference call and webcast on November 13, 2026, at 9:00 AM ET to review the unaudited financial results. Interested parties may access the conference call by ...

GAITHERSBURG, MD., US, November 6, 2026) Immunocore Holdings plc (Nasdaq: IMCR) (“Immunocore” or the “Company”), a commercial-stage biotechnology company pioneering and delivering transformative ...